Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06457152 · ClinicalTrials.gov registry record · NA
Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure
A NA study of Heart Failure, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 3,000
- Enrollment target
- 4
- Study locations
NCT06457152 is a NA study of Heart Failure that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 3,000 participants, above the 2,041-participant average among 397 other Heart Failure trials with a reported enrollment target (47% higher). The trial reports 4 study locations across 4 states.
The verdict
NCT06457152, a NA study of Heart Failure, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 3,000 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will test an automated, electronic health record (EHR-)embedded alert to improve prescribing of guideline-directed medical therapy for patients with heart failure and reduced ejection fraction (HFrEF). The investigators have previously tested and implemented this alert at NYU Langone Health (NYULH), and will now test and implement this alert across three other health systems.
Conditions Studied
Interventions
- OTHER EHR-Emedded Alert
Study Locations (4)
Massachusetts
- University of Massachusetts - Boston
New York
- NYU Langone Health - New York
Ohio
- OhioHealth - Columbus
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2025-04-04 |
| Est. Completion | 2026-03-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06457152
The ClinicalTrials.gov registry entry for NCT06457152 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,041-participant average among 397 other Heart Failure trials with a reported enrollment target (47% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which EHR-Emedded Alert is the first listed.
NCT06457152 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT06457152 about?
NCT06457152 is a clinical study titled "Multi-Center Project: Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure". This study will test an automated, electronic health record (EHR-)embedded alert to improve prescribing of guideline-directed medical therapy for patients with heart failure and reduced ejection fraction (HFrEF). The investigators have previously tested and implemented this alert at NYU Langone Heal...
What is the current status of trial NCT06457152?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,000 participants. The study started on 2025-04-04. Estimated completion is 2026-03-29.
What conditions does trial NCT06457152 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT06457152?
The interventions under investigation include: EHR-Emedded Alert (OTHER).
Who is sponsoring clinical trial NCT06457152?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06457152 being conducted?
This trial has 4 study locations across Massachusetts, New York, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.